Regulacje i polityka gospodarcza · 22/11/1999

Government-Owned Invention; Availability for Licensing: ``Extracellular cAMP-Dependent Protein Kinase in the Diagnosis and Prognosis of Cancer and Methods of Treatment''

The invention listed below is owned by an agency of the U.S. Government and is available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of federally funded research and development.